Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies

Top Cited Papers
Open Access
Abstract
Aims To assess if treatment with the α-glucosidase inhibitor acarbose can reduce cardiovascular events in type 2 diabetic patients.Methods and result

This publication has 0 references indexed in Scilit: